Elevance Health, Inc. (LON:0HG8)
312.85
-4.11 (-1.30%)
At close: Nov 7, 2025
Elevance Health Revenue
Elevance Health had revenue of $50.71B USD in the quarter ending September 30, 2025, with 12.33% growth. This brings the company's revenue in the last twelve months to $194.82B, up 11.96% year-over-year. In the year 2024, Elevance Health had annual revenue of $176.81B with 3.19% growth.
Revenue (ttm)
$194.82B
Revenue Growth
+11.96%
P/S Ratio
0.37
Revenue / Employee
$1.87M
Employees
104,200
Market Cap
53.64B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 176.81B | 5.47B | 3.19% |
| Dec 31, 2023 | 171.34B | 14.74B | 9.41% |
| Dec 31, 2022 | 156.60B | 17.96B | 12.95% |
| Dec 31, 2021 | 138.64B | 16.78B | 13.76% |
| Dec 31, 2020 | 121.87B | 17.66B | 16.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Elevance Health News
- 5 days ago - Elevance Health (ELV) Sees Price Target Reduction by Mizuho | ELV Stock News - GuruFocus
- 5 days ago - Columbia Balanced Fund Q3 2025 Portfolio Update - Seeking Alpha
- 10 days ago - Artisan Global Value Fund Q3 2025 Portfolio Update - Seeking Alpha
- 10 days ago - Implied Volatility Surging for Elevance Health Stock Options - Nasdaq
- 15 days ago - Martin Zweig Detailed Fundamental Analysis - ELV - Nasdaq
- 16 days ago - Elevance Health Inc: A Key Exit in Eaton Vance Worldwide Health Sciences Fund's Q3 2025 Portfolio - GuruFocus
- 16 days ago - Elevance Health: Q3 Figures Underscore Slow But Steady Recovery - Seeking Alpha
- 16 days ago - Elevance Health Inc at Wells Fargo Healthcare Conference Transcript - GuruFocus